Effect of biogenic selenium nanoparticles on ERG11 and CDR1 gene expression in both fluconazole-resistant and -susceptible Candida albicans isolates
Author(s) -
Nasrin Parsamehr,
Sasan Rezaie,
Sadegh Khodavaisy,
Samira Salari,
Sanaz Hadizadeh,
Mohammad Kord,
Seyyed Amin Ayatollahi Mousavi
Publication year - 2017
Publication title -
current medical mycology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.369
H-Index - 6
eISSN - 2423-3439
pISSN - 2423-3420
DOI - 10.29252/cmm.3.3.16
Subject(s) - candida albicans , selenium , azole , fluconazole , corpus albicans , microbiology and biotechnology , gene , gene expression , biology , chemistry , antifungal , biochemistry , organic chemistry
Candida albicans is the most common Candida species (sp.) isolated from fungal infections. Azole resistance in Candida species has been considerably increased in the last decades. Given the toxicity of the antimicrobial drugs, resistance to antifungal agents, and drug interactions, the identification of new antifungal agents seems essential. In this study, we assessed the antifungal effects of biogenic selenium nanoparticles on C. albicans and determined the expression of ERG11 and CDR1 genes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom